title: Involvement of cytochrome P-450 1B1 in renal dysfunction, injury, and inflammation associated with angiotensin II-induced hypertension in rats.
abstract: We investigated the contribution of cytochrome P-450 1B1 (CYP1B1) to renal dysfunction and organ damage associated with ANG II-induced hypertension in rats. ANG II (300 ng·kg(-1)·min(-1)) or vehicle were infused for 2 wk, with daily injections of a selective CYP1B1 inhibitor, 2,4,3',5'-tetramethoxystilbene (TMS; 300 μg/kg ip), or its vehicle. ANG II increased blood pressure and renal CYP1B1 activity that were prevented by TMS. ANG II also increased water intake and urine output, decreased glomerular filtration rate, increased urinary Na(+) and K(+) excretion, and caused proteinuria, all of which were prevented by TMS. ANG II infusion caused hypertrophy, endothelial dysfunction, and increased reactivity of renal and interlobar arteries to vasoconstrictor agents and renal vascular resistance and interstitial fibrosis as indicated by accumulation of α-smooth muscle actin, fibronectin, and collagen, and inflammation as indicated by increased infiltration of CD-3(+) cells; these effects were inhibited by TMS. ANG II infusion also increased production of reactive oxygen species (ROS) and activities of NADPH oxidase, ERK1/2, p38 MAPK, and c-Src that were prevented by TMS. TMS alone had no effect on any of the above parameters. These data suggest that CYP1B1 contributes to the renal pathophysiological changes associated with ANG II-induced hypertension, most likely via increased ROS production and activation of ERK1/2, p38 MAPK, and c-Src and that CYP1B1 could serve as a novel target for treating renal disease associated with hypertension.
authors.affiliation: Dept. of Pharmacology, College of Medicine, Univ. of Tennessee Health Science Center, 874 Union Ave., Memphis, TN 38163, USA.
authors.forename: Brett L
authors.initials: BL
authors.lastname: Jennings
authors.forename: Larry J
authors.initials: LJ
authors.lastname: Anderson
authors.forename: Anne M
authors.initials: AM
authors.lastname: Estes
authors.forename: Xiao R
authors.initials: XR
authors.lastname: Fang
authors.forename: Chi Young
authors.initials: CY
authors.lastname: Song
authors.forename: William B
authors.initials: WB
authors.lastname: Campbell
authors.forename: Kafait U
authors.initials: KU
authors.lastname: Malik
mesh_terms: D000804:Angiotensin II / Q000633:toxicity*; D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D065633:Cytochrome P-450 CYP1B1; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006977:Hypertension, Renal / Q000139:chemically induced / Q000201:enzymology* / Q000503:physiopathology; D007249:Inflammation / Q000201:enzymology / Q000503:physiopathology; D007668:Kidney / Q000098:blood supply / Q000187:drug effects / Q000201:enzymology* / Q000503:physiopathology; D008297:Male; D019255:NADPH Oxidases / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D017382:Reactive Oxygen Species / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D013267:Stilbenes / Q000494:pharmacology
chemical_list: C440850:2,4,3',5'-tetramethoxystilbene; D017382:Reactive Oxygen Species; D013267:Stilbenes; D000804:Angiotensin II; D001189:Aryl Hydrocarbon Hydroxylases; C585499:Cyp1b1 protein, rat; D065633:Cytochrome P-450 CYP1B1; D019255:NADPH Oxidases
references.citation: Cancer Res. 2001 Nov 15;61(22):8164-70
references.pmid: 11719446
references.citation: Am J Physiol Regul Integr Comp Physiol. 2003 Apr;284(4):R893-912
references.pmid: 12626356
references.citation: Circ Res. 1998 Jun 29;82(12):1298-305
references.pmid: 9648726
references.citation: Biochem J. 1994 Apr 1;299 ( Pt 1):197-201
references.pmid: 8166641
references.citation: Hypertension. 2010 Jun;55(6):1425-30
references.pmid: 20404214
references.citation: Clin Sci (Lond). 2007 Apr;112(8):417-28
references.pmid: 17346243
references.citation: J Hypertens. 2010 May;28(5):1034-43
references.pmid: 20411599
references.citation: J Renin Angiotensin Aldosterone Syst. 2009 Mar;10(1):9-14
references.pmid: 19286753
references.citation: J Hypertens. 2007 Aug;25(8):1633-42
references.pmid: 17620960
references.citation: Am J Physiol. 1997 Feb;272(2 Pt 2):H648-56
references.pmid: 9124421
references.citation: J Histochem Cytochem. 2001 Feb;49(2):229-36
references.pmid: 11156691
references.citation: Am J Physiol Lung Cell Mol Physiol. 2008 May;294(5):L902-11
references.pmid: 18296498
references.citation: Am J Physiol Renal Physiol. 2011 Apr;300(4):F1008-16
references.pmid: 21270093
references.citation: Am J Physiol Regul Integr Comp Physiol. 2002 Jul;283(1):R60-8
references.pmid: 12069931
references.citation: Acta Pathol Microbiol Scand A. 1970;78(2):143-50
references.pmid: 4316934
references.citation: Hypertension. 2000 Oct;36(4):604-9
references.pmid: 11040243
references.citation: Am J Hypertens. 2011 Jan;24(1):114-8
references.pmid: 20706193
references.citation: Am J Physiol Renal Physiol. 2005 Sep;289(3):F496-503
references.pmid: 16093425
references.citation: Antioxid Redox Signal. 1999 Summer;1(2):167-79
references.pmid: 11228745
references.citation: Am J Physiol Renal Physiol. 2003 Apr;284(4):F863-9
references.pmid: 12505865
references.citation: Pharmacol Rev. 2007 Sep;59(3):251-87
references.pmid: 17878513
references.citation: Circ Res. 2004 Jul 23;95(2):210-6
references.pmid: 15192025
references.citation: Hypertension. 2000 Feb;35(2):587-94
references.pmid: 10679502
references.citation: J Clin Invest. 1996 Apr 15;97(8):1916-23
references.pmid: 8621776
references.citation: J Pharmacol Exp Ther. 2003 Sep;306(3):880-8
references.pmid: 12808005
references.citation: Circulation. 2000 Apr 11;101(14):1722-8
references.pmid: 10758056
references.citation: Hypertension. 2009 Jun;53(6):1048-53
references.pmid: 19433780
references.citation: Biomed Chromatogr. 2010 Dec;24(12):1373-8
references.pmid: 21077256
references.citation: Am J Physiol Renal Physiol. 2006 Jun;290(6):F1463-71
references.pmid: 16396943
references.citation: Hypertension. 2010 Aug;56(2):290-6
references.pmid: 20606111
references.citation: Hypertension. 2010 Jun;55(6):1461-7
references.pmid: 20439821
references.citation: J Biol Chem. 2002 Mar 22;277(12):9920-8
references.pmid: 11786549
references.citation: Am J Physiol Renal Physiol. 2010 Nov;299(5):F1141-50
references.pmid: 20739394
references.citation: J Biol Chem. 2007 Jun 8;282(23):16878-90
references.pmid: 17442668
references.citation: Acta Physiol (Oxf). 2007 Jan;189(1):77-85
references.pmid: 17280559
references.citation: Hypertension. 2010 Oct;56(4):667-74
references.pmid: 20805442
references.citation: J Pharmacol Exp Ther. 1998 Jan;284(1):388-98
references.pmid: 9435202
references.citation: Physiol Rev. 2002 Jan;82(1):131-85
references.pmid: 11773611
references.citation: Circ Res. 2010 Jul 23;107(2):263-70
references.pmid: 20558826
references.citation: Curr Opin Nephrol Hypertens. 2001 Mar;10(2):231-7
references.pmid: 11224699
references.citation: Hypertension. 2004 Apr;43(4):752-9
references.pmid: 14981064
references.citation: J Hypertens. 2006 Jan;24(1):75-84
references.pmid: 16331104
references.citation: Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H22-8
references.pmid: 15598867
references.citation: J Cardiovasc Pharmacol. 2007 Jun;49(6):362-8
references.pmid: 17577100
references.citation: Cell Physiol Biochem. 2007;19(1-4):121-8
references.pmid: 17310106
references.citation: Science. 1989 Jan 20;243(4889):388-90
references.pmid: 2492116
references.citation: Diabetes Care. 2008 Feb;31 Suppl 2:S170-80
references.pmid: 18227481
references.citation: Anal Biochem. 2001 Nov 15;298(2):327-36
references.pmid: 11700990
references.citation: Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1891-901
references.pmid: 20852048
references.citation: Am J Physiol. 1986 Jun;250(6 Pt 2):R960-72
references.pmid: 3521337
references.citation: Cardiovasc Res. 2006 Sep 1;71(4):794-802
references.pmid: 16822492
references.citation: Am J Physiol. 1994 Jan;266(1 Pt 2):F120-8
references.pmid: 8304477
references.citation: Am J Physiol. 1998 Aug;275(2):R426-38
references.pmid: 9688677
references.citation: J Clin Invest. 2005 Apr;115(4):1092-9
references.pmid: 15841186
references.citation: Hypertension. 1995 Jun;25(6):1252-9
references.pmid: 7768570
references.citation: Hypertension. 1998 Jan;31(1 Pt 2):242-7
references.pmid: 9453310
references.citation: Hypertension. 2008 Aug;52(2):256-63
references.pmid: 18541733
references.citation: Drug Metab Dispos. 2004 Aug;32(8):840-7
references.pmid: 15258110